Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 20.1B | 20.4B | 20.4B | 20.7B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 9.8B | 9.5B | 8.9B | 8.8B |
Other operating expenses | — | — | — | — |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 5.3B | 5.4B | 6.2B | 6.2B |
Tax provision | 522M | 120M | 1.1B | 1.3B |
Net income | 4.8B | 5.3B | 5.2B | 4.9B |
Basic EPS | 1.4 | 1.5 | 1.4 | 1.4 |
Diluted EPS | 1.4 | 1.4 | 1.4 | 1.3 |
Basic average shares | 3.3B | 3.3B | 3.4B | 3.4B |
Diluted average shares | 3.3B | 3.4B | 3.4B | 3.5B |
EBITDA | — | — | — | — |
Net income from continuing op. | 4.8B | 5.3B | 5.2B | 4.9B |
Minority interests | 90M | -184M | -56M | 1M |
Preferred stock dividends | — | — | — | — |